Información General

• Autores: Jose Luis Garcia Gimenez (coord.)
• Editores: Amsterdam [etc.]: Elsevier, 2016
• Año de publicación: 2016
• País: España
• Idioma: español
• ISBN: 9780128018996
• Texto completo no disponible (Saber más ...)

Resumen

• This book explores the intersection between epigenetic biomarkers and clinical diagnostics, and is divided into three distinct sections, including the basis of epigenetic mechanisms, the importance of the sample quality, and the technologies and methods used to discover and analyze epigenetic biomarkers.

Otros catálogos

• Red de Bibliotecas Universitarias (REBIUN)

Listado de artículos

• • Epigenetic biomarkers: New findings, perspectives and future directions in diagnostics

    Jose Luis Garcia Gimenez, Toshikazu Ushijima, Trygve O. Tollefsbol

    págs. 2-19

    

  • The importance of biobanks in epigenetic studies

    Lorena Peiró Chova, Olga Bahamonde Ponce, Carolina Abril-Tormo, Jacobo Martínez Santamaría, José Antonio López Guerrero, Peter H. J. Riegman

    págs. 20-37

    

  • Epigenetic mechanisms as key regulators in disease: Clinical implications

    Abdelhalim Boukaba, Fabian Sanchis Gomar, Jose Luis Garcia Gimenez

    págs. 38-67

    

  • The evolution of new technologies and methods in clinical epigenetics research

    Tandy L.D. Petrov, Nicole C. Riddle

    págs. 68-91

    

  • Biomarkers and methodologies for monitoring epigenetic drug effects in cancer

    Marianne B. Treppendahl, Lasse Sommer Kristensen, Kirsten Gronbaek

    págs. 92-118

    

  • Genome-wide techniques for the study of clinical epigenetic biomarkers

    Eneda Toska, Francisco Javier Carmona Sanz

    págs. 119-137

    

  • Sequenom MassARRAY technology analysis of DNA methylation: Clinical applications

    Enrique J. Busó, Marisa Iborra

    págs. 138-155

    

  • The role of methylation-specific PCR and associated techniques in clinical diagnostics

    Fang Zhao, Bharati Bapat

    págs. 156-174

    

  • Pyrosequencing and its applicationin epigenetic clinical diagnostics

    Ana Maria Florea

    págs. 175-195

    

  • Mass spectrometry for the identification of posttranslational modifications in histones and its application in clinical epigenetics

    Roberta Noberini, Alessandro Cuomo, Tiziana Bonaldi

    págs. 196-215

    

  • High-throughput analysis of noncoding RNAs: Implications in clinical epigenetics

    Valerio Costa, Maria R. Matarazzo, Miriam Gagliardi, Roberta Esposito, Alfredo Ciccodicola

    págs. 216-239

    

  • Circulating noncoding RNAs as clinical biomarkers

    Francesco Russo, Flavia Scoyni, Alessandro Fatica, Marco Pellegrini, Alfredo Ferro, Alfredo Pulvirenti, Rosalba Giugno

    págs. 240-258

    

  • DNA methylation biomarkers in lung cancer

    Juan Sandoval, Paula López Serra

    págs. 259-274

    

  • DNA methylation alterations as biomarkers for prostate cancer

    Joao Ramalho-Carvalho, Rui Henrique, Carmen Jerónimo

    págs. 275-290

    

  • DNA methylation in breast cancer

    Raimundo Cervera, Alberto Ramos, Ana Lluch Hernández, Joan Climent

    págs. 297-312

    

  • DNA methylation in obesity and associated diseases

    Ana Belén Crujeiras Martínez, Angel Diaz Lagares

    págs. 313-330

    

  • DNA methylation biomarkers in asthma and allergy

    Avery DeVries, Donata Vercelli

    págs. 331-351

    

  • DNA methylation for prediction of adverse pregnancy outcomes

    Deepali Sundrani, Vinita Khot, Sadhana Joshi

    págs. 352-376

    

  • Epigenetics in infectious diseases

    Genevieve Syn, Jenefer M. Blackwell, Sarra E. Jamieson

    págs. 377-400

    

  • DNA methylation in neurodegenerative diseases

    Sahar Al-Mahdawi, Sara Anjomani Virmouni, Mark A. Pook

    págs. 401-417

    

  • The histone code and disease: Posttranslational modifications as potential prognostic factors for clinical diagnosis

    Nicolas G. Simonet, George Rasti, Alejandro Vaquero García

    págs. 418-447

    

  • Histone posttranslational modifications and chromatin remodelers in prostate cancer

    Filipa Quintela Vieira, Diogo Almeida-Rios, Inés Graça, Rui Henrique, Carmen Jerónimo

    págs. 448-467

    

  • Histone posttranslational modifications in breast cancer and their use in clinical diagnosis and prognosis

    Luca Magnani, Annita Louloupi, Wilbert Zwart

    págs. 468-480

    

  • Histone variants and posttranslational modifications in spermatogenesis and infertility

    Juan Ausio, Yinan Zhang, Toyotaka Ishibashi

    págs. 480-497

    

  • Circulating histones and nucleosomes as biomarkers in sepsis and septic shock

    Jose Luis Garcia Gimenez, Carlos Romá-Mateo, Marta Seco Cervera, José Santiago Ibáñez Cabellos, Federico V. Pallardó Calatayud

    págs. 498-519

    

  • Chromatin landscape and epigenetic signatures in neurological disorders: Emerging perspectives for biological and clinical research

    Pamela Milani, Ernest Fraenkel

    págs. 520-539

    

  • MicroRNA deregulation in lung cancer and their use as clinical tools

    Paula López Serra, Juan Sandoval

    • Resumen

    págs. 540-556

    

  • Circulating nucleic acids as prostate cancer biomarkers

    Claire E. Fletcher, Ailsa Sita-Lumsden, Akifumi Shibakawa, Charlotte L. Bevan

    págs. 557-587

    

  • MicroRNAs in breast cancer and their value as biomarkers

    Olafur Andri Stefansson

    págs. 588-613

    

  • MicroRNAs in bone and soft tissue sarcomas and their value as biomarkers614

    Tomohiro Fujiwara, Yu Fujita, Yutaka Nezu, Akira Kawai, Toshifumi Ozaki, Ochiya Takahiro

    págs. 614-643

    

  • MiRNAs in the pathophysiology of diabetes and their value as biomarkers

    Eoin Brennan, Aaron McClelland, Shinji Hagiwara, Catherine Godson, Phillip Kantharidis

    págs. 644-662